Research Articles
DOI DOI: 10.62063/ecb-59

Correlation of ferritin, D-dimer, and CRP with disease severity and outcome in COVID-19 patients

Ia Murvanidze1, Ilia Nakashidze2, Teona Gogitidze3, Ermira Jahja4, Aleena Parveen Shaikh1, Nino Tebidze5, Nameera Parveen Shaikh5, Besik Kakabadze2, Maia Resulidze2, Rajneesh Khurana6, Eteri Saralidze2, Otar Tsetskhladze 2, Davit Baratashvili2, Nino Kedelidze2, Tamar Peshkova2, Irina Nakashidze1
  1. 1 Batumi Shota Rustaveli State University
  2. 2 Batumi Shota Rustaveli State University
  3. 3 BAU International University
  4. 4 Western Balkans University
  5. 5 BAU International University
  6. 6 Montefiore Medical Center

Abstract

Higher levels of ferritin were associated with severe forms of COVID-19 disease. Given the above, our goal was to investigate the associations between ferritin levels within COVID-19-infected individuals from the Adjara population (Georgia). A nasopharyngeal swab was collected from 318 individuals, and SARS-CoV-2 infection was detected using the polymerase chain reaction (PCR) method. Ferritin levels were also investigated in the blood serum of the same individuals. Thus, the study of ferritin in COVID-19 patients (in the Adjara population revealed significantly higher ferritin levels in COVID-19 patients. Higher levels of ferritin were detected in the male subjects than in the female population (p=0.0001). COVID-19 patients with lethal outcomes had nearly ~3 times higher levels of ferritin than the reference value, while those who successfully recovered had ~1.9 times above the reference value. It should be noted that the individuals with lethal outcomes were between 81 and 90 years old. An increased level of D-dimer compared to the reference level was also detected in the male population and was nearly ~4.1 times higher in those with lethal outcomes. D-dimer was also significantly increased in patients at the age 71-80 years, while their CRP levels were approximately ~5.8 times above the reference level; Moreover, CRP level was ~24.4 times increased in the case of women with lethal outcomes; In particular, according to the comparing age groups, a high level of CRP was observed in 61-70 years patients. Our study revealed that the diseased population exhibited significantly higher ferritin levels. The ferritin levels in patients with lethal outcomes were considerably higher than those in patients who successfully recovered.  Thus, the findings reveal a noteworthy elevation in D-dimer levels, particularly in men and deceased patients, with a notable elevation in the 71-80 age group. Additionally, CRP levels were markedly higher, especially among deceased women and individuals aged 61-70. 

How to Cite

Murvanidze, I., Nakashidze, I., Gogitidze, T., Jahja, E., Shaikh, A. P., Tebidze, N., … Nakashidze, I. (2025). Correlation of ferritin, D-dimer, and CRP with disease severity and outcome in COVID-19 patients. The European Chemistry and Biotechnology Journal, (4), 24–39. https://doi.org/10.62063/ecb-59
Endnote/Zotero/Mendeley (RIS) BibTeX

References

  1. Black, S., Kushner, I., & Samols, D. (2004). C-reactive protein. Journal of Biological Chemistry, 279(47), 48487–48490. https://doi.org/10.1074/jbc.R400025200
  2. Carubbi, F., Salvati, L., Alunno, A., Maggi, F., Borghi, E., Mariani, R., Mai, F., Paoloni, M., Ferri, C., Desideri, G., Cicogna, S., & Grassi, D. (2021). Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: Data from two Italian COVID-19 units. Scientific Reports, 11(1), 4863. https://doi.org/10.1038/s41598-021-83831-8
  3. Ceci, F. M., Fiore, M., Gavaruzzi, F., Angeloni, A., Lucarelli, M., Scagnolari, C., Bonci, E., Gabanella, F., Di Certo, M. G., Barbato, C., Petrella, C., Greco, A., De Vincentiis, M., Ralli, M., Passananti, C., Poscia, R., Minni, A., Ceccanti, M., Tarani, L., & Ferraguti, G. (2022). Early routine biomarkers of SARS-CoV-2 morbidity and mortality: Outcomes from an emergency section. Diagnostics, 12(1), 176. https://doi.org/10.3390/diagnostics12010176
  4. Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet, 395(10223), 507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
  5. Cheng, L., Li, H., Li, L., Liu, C., Yan, S., Chen, H., & Li, Y. (2020). Ferritin in the coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis. Journal of Clinical Laboratory Analysis, 34(10), e23618. https://doi.org/10.1002/jcla.23618
  6. Colafrancesco, S., Alessandri, C., Conti, F., & Priori, R. (2020). COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? Autoimmunity Reviews, 19(7), 102573. https://doi.org/10.1016/j.autrev.2020.102573
  7. De Gonzalo-Calvo, D., Benítez, I. D., Pinilla, L., Carratalá, A., Moncusí-Moix, A., Gort-Paniello, C., Molinero, M., González, J., Torres, G., Bernal, M., Pico, S., Almansa, R., Jorge, N., Ortega, A., Bustamante-Munguira, E., Gómez, J. M., González-Rivera, M., Micheloud, D., Ryan, P., Martinez, A., Tamayo, L., Aldecoa, C., Ferrer, R., Ceccato, A., Fernandez-Barat, L., Motos, A., Riera, J., Menendez, R., Garcia-Gasulla, D., Penuelas, O., Torres, A., Bermejo-Martin, J.F., & Barbé, F. (2021). Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients. Translational Research, 236, 147–159. https://doi.org/10.1016/j.trsl.2021.05.004
  8. Ergun, S., Sankaranarayanan, R., & Petrović, N. (2023). Clinically informative microRNAs for SARS-CoV-2 infection. Epigenomics. https://doi.org/10.2217/epi-2023-0179
  9. Feld, J., Tremblay, D., Thibaud, S., Kessler, A., & Naymagon, L. (2020). Ferritin levels in patients with COVID‐19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis. International Journal of Laboratory Hematology, 42(6), 773–779. https://doi.org/10.1111/ijlh.13309
  10. Feng, Y., Liu, J., Kang, Y., He, Y., Liang, B., Yang, P., & Yu, Z. (2014). miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer. Journal of Experimental & Clinical Cancer Research, 33(1), 67. https://doi.org/10.1186/s13046-014-0067-8
  11. Fox, S. E., Akmatbekov, A., Harbert, J. L., Li, G., Brown, J. Q., & Vander Heide, R. S. (2020). Pulmonary and cardiac pathology in African American patients with COVID-19: An autopsy series from New Orleans. The Lancet Respiratory Medicine, 8(7), 681–686. https://doi.org/10.1016/S2213-2600(20)30243-5
  12. Gao, Y., Li, T., Han, M., Li, X., Wu, D., Xu, Y., Zhu, Y., Liu, Y., Wang, X., & Wang, L. (2020). Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19. Journal of Medical Virology, 92(7), 791–796. https://doi.org/10.1002/jmv.25770
  13. Ghafouri-Fard, S., Khoshbakht, T., Hussen, B. M., Abdullah, S. T., Taheri, M., & Samadian, M. (2022). A review on the role of miR-16-5p in the carcinogenesis. Cancer Cell International, 22(1), 342. https://doi.org/10.1186/s12935-022-02754-0
  14. Gómez-Pastora, J., Weigand, M., Kim, J., Wu, X., Strayer, J., Palmer, A. F., Zborowski, M., Yazer, M., & Chalmers, J. J. (2020). Hyperferritinemia in critically ill COVID-19 patients—Is ferritin the product of inflammation or a pathogenic mediator? Clinica Chimica Acta, 509, 249–251. https://doi.org/10.1016/j.cca.2020.06.033
  15. Guo, W., Li, M., Dong, Y., Zhou, H., Zhang, Z., Tian, C., Qin, R., Wang, H., Shen, Y., Du, K., Zhao, L., Fan, H., Luo, S., & Hu, D. (2020). Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes/Metabolism Research and Reviews, 36(7), e3319. https://doi.org/10.1002/dmrr.3319
  16. Hadi, J. M., Mohammad, H. M., Ahmed, A. Y., Tofiq, S. S., Abdalrahman, L. B., Qasm, A. A., & Ameer, A. M. (2022). Investigation of serum ferritin for the prediction of COVID-19 severity and mortality: A cross-sectional study. Cureus. https://doi.org/10.7759/cureus.31982
  17. Huang, I., Pranata, R., Lim, M. A., Oehadian, A., & Alisjahbana, B. (2020). C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: A meta-analysis. Therapeutic Advances in Respiratory Disease, 14, 175346662093717. https://doi.org/10.1177/1753466620937175
  18. Kappert, K., Jahić, A., & Tauber, R. (2020). Assessment of serum ferritin as a biomarker in COVID-19: Bystander or participant? Insights by comparison with other infectious and non-infectious diseases. Biomarkers, 25(8), 616–625. https://doi.org/10.1080/1354750X.2020.1797880
  19. Linarez Ochoa, N. E., Rodríguez, G., Reyes, I. D., Rico Rivas, K. M., Ramírez, C., & Durón, R. M. (2022). Differences in inflammatory markers between coronavirus disease 2019 and sepsis in hospitalised patients. Clinical Epidemiology and Global Health, 15, 101059. https://doi.org/10.1016/j.cegh.2022.101059
  20. Liu, T., Zhang, J., Yang, Y., Ma, H., Li, Z., Zhang, J., Cheng, J., Zhang, X., Zhao, Y., Xia, Z., Zhang, L., Wu, G., & Yi, J. (2020). The role of interleukin‐6 in monitoring severe cases of coronavirus disease 2019. EMBO Molecular Medicine, 12(7), e12421. https://doi.org/10.15252/emmm.202012421
  21. Luo, W. R., Yu, H., Gou, J. Z., Li, X. X., Sun, Y., Li, J. X., He, J. X., & Liu, L. (2020). Histopathologic Findings in the Explant Lungs of a Patient With COVID-19 Treated With Bilateral Orthotopic Lung Transplant. Transplantation, 104(11), e329-e331. https://doi.org/10.1097/TP.0000000000003412
  22. Maatman, T. K., Jalali, F., Feizpour, C., Douglas, A., McGuire, S. P., Kinnaman, G., Hartwell, J. L., Maatman, B. T., Kreutz, R. P., Kapoor, R., Rahman, O., Zyromski, N. J., & Meagher, A. D. (2020). Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019. Critical Care Medicine, 48(9), e783–e790. https://doi.org/10.1097/CCM.0000000000004466
  23. Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020). COVID-19: Consider cytokine storm syndromes and immunosuppression. The Lancet, 395(10229), 1033–1034. https://doi.org/10.1016/S0140-6736(20)30628-0
  24. Murvanidze, I., Tsetskhladze, O., Saralidze, E., Gogitidze, T., Khurana, R., Kedelidze, N., Peshkova, T., Nakashidze, I., & Nakashidze, I. (2023). The study of liver and kidney function within COVID-19 patients. Georgian Medical News, 337, 96–98.
  25. Nauka, P. C., Baron, S. W., Assa, A., Mohrmann, L., Jindal, S., Oran, E., Glazman-Kuczaj, G., Southern, W. N., & Chekuri, S. (2021). Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors. Thrombosis research, 199, 82–84. https://doi.org/10.1016/j.thromres.2020.12.023
  26. Para, O., Caruso, L., Pestelli, G., Tangianu, F., Carrara, D., Maddaluni, L., Tamburello, A., Castelnovo, L., Fedi, G., Guidi, S., Pestelli, C., Pennella, B., Ciarambino, T., Nozzoli, C., & Dentali, F. (2022). Ferritin as prognostic marker in COVID-19: The FerVid study. Postgraduate Medicine, 134(1), 58–63. https://doi.org/10.1080/00325481.2021.1990091
  27. Poudel, A., Poudel, Y., Adhikari, A., Aryal, B. B., Dangol, D., Bajracharya, T., Maharjan, A., & Gautam, R. (2021). D-Dimer as a biomarker for assessment of COVID-19 prognosis: D-Dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. PLOS ONE, 16(8), e0256744. https://doi.org/10.1371/journal.pone.0256744
  28. Ruddell, R. G., Hoang-Le, D., Barwood, J. M., Rutherford, P. S., Piva, T. J., Watters, D. J., Santambrogio, P., Arosio, P., & Ramm, G. A. (2009). Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology, 49(3), 887–900. https://doi.org/10.1002/hep.22716
  29. Sakka, M., Connors, J. M., Hékimian, G., Martin-Toutain, I., Crichi, B., Colmegna, I., Bonnefont-Rousselot, D., Farge, D., & Frere, C. (2020). Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and pooled analysis. JMV-Journal de Médecine Vasculaire, 45(5), 268–274. https://doi.org/10.1016/j.jdmv.2020.05.003
  30. Santos-Poleo, Y. D., Perez-Sanchez, L., Ocanto, A., Oquillas-Izquierdo, D., & Rodriguez-Recio, F. (2020). Elevated D-dimer and acute pulmonary thromboembolism in patients with COVID-19. Journal of Negative and No Positive Results , 5(12), 1516-1527. https://doi.org/10.19230/jonnpr.3960
  31. Shakaroun, D. A., Lazar, M. H., Horowitz, J. C., & Jennings, J. H. (2023). Serum ferritin as a predictor of outcomes in hospitalized patients with COVID-19 pneumonia. Journal of Intensive Care Medicine, 38(1), 21–26. https://doi.org/10.1177/08850666221113252
  32. Sproston, N. R., & Ashworth, J. J. (2018). Role of C-reactive protein at sites of inflammation and infection. Frontiers in Immunology, 9, 754. https://doi.org/10.3389/fimmu.2018.00754
  33. Tang, N., Li, D., Wang, X., & Sun, Z. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis, 18(4), 844–847. https://doi.org/10.1111/jth.14768
  34. Vargas-Vargas, M., & Cortés-Rojo, C. (2020). Ferritin levels and COVID-19. Revista Panamericana de Salud Pública, 44, e72. https://doi.org/10.26633/RPSP.2020.72
  35. Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., & Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA, 323(11), 1061–1069. https://doi.org/10.1001/jama.2020.1585
  36. Wu, J., Liu, J., Zhao, X., Liu, C., Wang, W., Wang, D., Xu, W., Zhang, C., Yu, J., Jiang, B., Cao, H., & Li, L. (2020). Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: A multicenter descriptive study. Clinical Infectious Diseases, 71(15), 706–712. https://doi.org/10.1093/cid/ciaa199
  37. Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet, 395(10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3